{
    "clinical_study": {
        "@rank": "166515", 
        "acronym": "ESSBR", 
        "arm_group": [
            {
                "arm_group_label": "Breast reconstruction, direct to implant with Strattice", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects undergoing immediate post-mastectomy breast reconstruction with a breast implant and Strattice\u2122"
            }, 
            {
                "arm_group_label": "Two stage breast reconstruction", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects undergoing immediate, two-stage post-mastectomy breast reconstruction without reinforcement."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective, multicenter, non-randomised, parallel design comparing a primary\n      Efficacy and primary Safety endpoint between subjects undergoing immediate post-mastectomy\n      breast reconstruction with a breast implant and Strattice\u2122 Reconstructive Tissue Matrix (TM)\n      and subjects undergoing immediate, two-stage post-mastectomy breast reconstruction, where\n      the initially placed expander will be exchanged for a breast implant only, without any type\n      of reinforcement.\n\n      The study objectives will be achieved by prospectively assessing the number of planned and\n      unplanned post-mastectomy surgical interventions within 12 months of the mastectomy.\n\n      Direct to Implant (DTI) breast reconstruction will include the use of Strattice\u2122 TM for\n      reinforcement of tissue during surgery.\n\n      Two-stage breast reconstruction will include the initial placement of a tissue expander\n      without mesh or flap reinforcement. The expander will be inflated over the next months, and\n      then replaced with an implant."
        }, 
        "brief_title": "Efficacy of Single Stage Breast Reconstruction", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Mastectomy and Breast Reconstruction", 
        "detailed_description": {
            "textblock": "This prospective, multicenter, non-randomised, parallel design will assess the clinical\n      outcomes of immediate single-stage breast reconstruction, DTI, with support of Strattice\u2122 TM\n      compared to immediate, two-stage breast reconstruction without support of any mesh or\n      autologous flap. The two-stage reconstruction control arm comprises initial expander\n      placement, followed by exchange of expander to a permanent implant at 1 to a maximum of 6\n      months after expander placement and fill.\n\n      All subjects will be undergoing immediate post-mastectomy breast reconstruction with partial\n      or full muscle coverage of the implant. Study subjects who need to undergo radiotherapy\n      post-mastectomy, either planned or unplanned, are also allowed to participate in the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Female 18 years or older\n\n          2. A candidate for both arms of the study involving immediate breast reconstruction\n             post-skin sparing mastectomy (unilateral or bilateral) (DTI with the use of Strattice\n             TM, 2 stage with use of Tissue Expander through exchange to Implant without support\n             of a mesh or autologous tissue)\n\n          3. An American Society of Anesthesiologists (ASA) Physical Status Classification of 1 or\n             2\n\n          4. Estimated life expectancy > 3 years\n\n          5. Able and willing to return for all scheduled and required study visits\n\n          6. Able to provide written informed consent for study participation\n\n        Exclusion Criteria:\n\n          1. Clinically significant systemic disease, as determined by the Investigator, which\n             could affect study participation or study results\n\n          2. Received neo-adjuvant, inductive chemo-therapy (except Herceptin, or other targeted\n             therapy) within 4 weeks prior to mastectomy\n\n          3. Previous radiation therapy to either breast at any time\n\n          4. Predicted implant size that is greater than or equal to 500 gms, per Investigator\n             assessment\n\n          5. BMI <17 or > 30\n\n          6. Co-morbid factors which predispose to postoperative infection, e.g. diabetes,\n             collagen vascular disease, chronic steroid (except inhalers)/immunosuppressant use,\n             immune deficiency, or co-existent infection\n\n          7. Pregnant or lactating\n\n          8. 3rd degree ptosis\n\n          9. Prior breast surgery including: breast reduction, augmentation, mastopexy,\n             quadrectomy, and partial mastectomy with reduction of the skin envelope\n\n         10. Prior use of a device (mesh or matrix) in the Breast\n\n         11. Concomitant unrelated condition of breast/chest wall/skin that, as determined by the\n             investigator, could adversely affect the surgical outcome (e.g. significant chest\n             wall abnormalities including pectus excavatum or pectus carinatum)\n\n         12. Planned autologous tissue flap in addition to prosthetic implant\n\n         13. Use of permanent expander implants such as Becker expanders or the Natrelle\n             Anatomical Permanent expander 150\n\n         14. Current alcohol abuse, illicit drug use, significant mental illness, physical\n             dependence to any opioid, or drug abuse or addiction\n\n         15. Currently enrolled or plans to enroll in another clinical trial unless it is: a\n             registry, a retrospective study, a neo-adjuvant chemotherapy trial (as long as the\n             chemotherapy regimen has been stopped 4 weeks prior to mastectomy), or a\n             hormone/anti-hormonal therapy trial\n\n         16. Any of the conditions identified within the labeled contraindications, i.e.\n             sensitivity to porcine derived products or polysorbate 20."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01910298", 
            "org_study_id": "LFC 2012.06.01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Breast reconstruction, direct to implant with Strattice", 
                "intervention_name": "Breast reconstruction, direct to implant with Strattice", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Two stage breast reconstruction", 
                "intervention_name": "Two stage breast reconstruction", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast reconstruction", 
            "Breast implant", 
            "Breast cancer", 
            "Mastectomy"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": [
            {
                "contact": {
                    "email": "m.fournier@bordeaux.unicancer.fr", 
                    "last_name": "Dr. Marion Fournier, MD", 
                    "phone": "+33 556 333 335"
                }, 
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "Institut Bergonie"
                }, 
                "investigator": {
                    "last_name": "Dr. Marion Fournier", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mp-chauvet@o-lambret.fr", 
                    "last_name": "Dr. Marie-Pierre Chauvet, MD", 
                    "phone": "+ 33 3 20 29 59 06"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille Cedex", 
                        "country": "France", 
                        "zip": "59000"
                    }, 
                    "name": "Centre Oscar Lambret"
                }, 
                "investigator": {
                    "last_name": "Dr. Marie-Pierre Chauvet", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Virginie.Bordes@ico.unicancer.fr", 
                    "last_name": "Dr. Virginie Bordes, MD", 
                    "phone": "+33 2 40 67 99 28"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes, Saint Herblain, Cedex", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "Centre Ren\u00e9 Gauducheau"
                }, 
                "investigator": {
                    "last_name": "Dr. Virginie Bordes", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dr. Michael Atlan"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Hopital Tenon APHP"
                }, 
                "investigator": {
                    "last_name": "Dr Michael Atlan", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "krishna.clough@orange.fr", 
                    "last_name": "Dr. Krishna Clough, MD", 
                    "phone": "+ 33 1 45 63 00 00"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75116"
                    }, 
                    "name": "L'Institut du Sein- Paris Breast Center"
                }, 
                "investigator": {
                    "last_name": "Dr. Krishna Clough", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Michael.Lux@uk-erlangen.de", 
                    "last_name": "PD Dr. med. Michael Lux, MD", 
                    "phone": "+49 9131 85-33553"
                }, 
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany", 
                        "zip": "91054"
                    }, 
                    "name": "Universit\u00e4tsklinikum Erlangen"
                }, 
                "investigator": {
                    "last_name": "PD Dr. med. Michael Lux", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "k.breuing@kliniken-essen-mitte.de", 
                    "last_name": "Dr. Karl Breuing, MD, FACS", 
                    "phone": "+49 201 17433509"
                }, 
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "zip": "45131"
                    }, 
                    "name": "Brustzentrum klinikum, Alfried Krupp Krankenhaus,"
                }, 
                "investigator": {
                    "last_name": "Dr. Karl Breuing", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Hille-Betz.Ursula@mh-hannover.de", 
                    "last_name": "OA Dr. med. Ursula Hille-Betz, MD", 
                    "phone": "+49511/532-9563"
                }, 
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Medizinische Hochschule Hannover"
                }, 
                "investigator": {
                    "last_name": "OA Dr. med. Ursula Hille-Betz", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "florian.schuetz@med.uni-heidelberg.de", 
                    "last_name": "Prof. Dr. med. Florian Sch\u00fctz", 
                    "phone": "+49 6221 563 7688"
                }, 
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany", 
                        "zip": "69115"
                    }, 
                    "name": "Universit\u00e4ts-Frauenklinik Heidelberg"
                }, 
                "investigator": {
                    "last_name": "Prof. Dr. med. Florian Schuetz", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Stefan.Paepke@lrz.tum.de", 
                    "last_name": "Dr. med. Stefan P\u00e4pke, MD", 
                    "phone": "+49 89 41405433"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "81675"
                    }, 
                    "name": "Klinikum rechts der Isar"
                }, 
                "investigator": {
                    "last_name": "Dr. med. Stefan Paepke", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Darius.Dian@med.uni-muenchen.de", 
                    "last_name": "PD Dr. med. Darius Dian, MD", 
                    "phone": "+49 89 5160 4111"
                }, 
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80337"
                    }, 
                    "name": "Klinik der Universit\u00e4t M\u00fcnchen, Campus Innenstadt"
                }, 
                "investigator": {
                    "last_name": "PD Dr. med. Darius Dian", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "v.heyl@asklepios.com", 
                    "last_name": "Volker Heyl, MD", 
                    "phone": "+49 611 847 2391"
                }, 
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany", 
                        "zip": "65197"
                    }, 
                    "name": "Asklepios Paulinen Klinik"
                }, 
                "investigator": {
                    "last_name": "Dr. med. Volker Heyl", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Richard.Linforth@bthft.nhs.uk", 
                    "last_name": "Mr. Rick Linforth", 
                    "phone": "+44 1274 383787"
                }, 
                "facility": {
                    "address": {
                        "city": "Bradford", 
                        "country": "United Kingdom", 
                        "zip": "BD5 0NA"
                    }, 
                    "name": "St Luke's hospital / Bradford Royal Infirmary (BRI)"
                }, 
                "investigator": {
                    "last_name": "Mr. Richard Linforth", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jmd@ed.ac.uk", 
                    "last_name": "Prof. Mike Dixon", 
                    "phone": "+44 131 537 2643"
                }, 
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "zip": "EH4 2XU"
                    }, 
                    "name": "Western General Hospital"
                }, 
                "investigator": {
                    "last_name": "Prof. Mike Dixon", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "raouf.daoud@fph-tr.nhs.uk", 
                    "last_name": "Mr. Raouf Daoud", 
                    "phone": "+44 7951705595"
                }, 
                "facility": {
                    "address": {
                        "city": "Frimley", 
                        "country": "United Kingdom", 
                        "zip": "GU16 7UJ"
                    }, 
                    "name": "Frimley Park Hospital"
                }, 
                "investigator": {
                    "last_name": "Mr. Raouf Daoud", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Douglas.Macmillan@nottingham.ac.uk", 
                    "last_name": "Mr. Douglas Macmillan", 
                    "phone": "+44 115 969 1169"
                }, 
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "zip": "NG5 1PB"
                    }, 
                    "name": "City Hospital"
                }, 
                "investigator": {
                    "last_name": "Mr. Douglas Macmillan", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "richard.johnson@UHSM.NHS.UK", 
                    "last_name": "Mr. Richard , Johnson", 
                    "phone": "+44 (0)161 291 4432"
                }, 
                "facility": {
                    "address": {
                        "city": "Wythenshawe Manchester", 
                        "country": "United Kingdom", 
                        "zip": "M23 9LT"
                    }, 
                    "name": "Wythenshawe Hospital UHSM NHS Foundation Trust"
                }, 
                "investigator": {
                    "last_name": "Mr. Richard Johnson", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Germany", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Multicenter, Controlled Study of Implant-based Breast Reconstruction, Measuring the Safety, Efficacy and Outcomes, of Immediate Single Stage Breast Reconstruction With Strattice\u2122 Reconstructive Tissue Matrix Versus Immediate Two Stage Breast Reconstruction Without Strattice\u2122 TM .", 
        "other_outcome": [
            {
                "description": "Per breast and per subject", 
                "measure": "Number of planned and unplanned post-mastectomy surgical interventions", 
                "safety_issue": "No", 
                "time_frame": "At 6 months post-mastectomy and at 24 months post-permanent reconstruction"
            }, 
            {
                "description": "Measured through questionnaires (EQ-5D and Breast-Q) and time to return to work or normal daily activities.", 
                "measure": "Quality of Life of subjects", 
                "safety_issue": "No", 
                "time_frame": "At 3, 6, and 12 months post-mastectomy and at 24 months post-permanent reconstruction"
            }, 
            {
                "description": "Per subject, including expansion visits in the two stage reconstruction arm", 
                "measure": "Number of hospital/clinic visits", 
                "safety_issue": "No", 
                "time_frame": "At 6 and 12 months post-mastectomy and at 24 months post-permanent reconstruction"
            }, 
            {
                "description": "From initial surgery to surgeon-subject agreement that reconstruction is complete.", 
                "measure": "Overall breast-mound reconstruction", 
                "safety_issue": "Yes", 
                "time_frame": "At 24 months post-permanent reconstruction"
            }, 
            {
                "description": "Blinded assessment of 2D photographs by an independent reviewer panel", 
                "measure": "Aesthetic outcomes of subjects", 
                "safety_issue": "No", 
                "time_frame": "At 12 months post-mastectomy at 12 months post-mastectomy and at 24 months post-permanent reconstruction"
            }, 
            {
                "description": "Investigator assessment", 
                "measure": "Surgeon satisfaction scores of subjects", 
                "safety_issue": "No", 
                "time_frame": "At 6 and 12 months post-mastectomy and 24 months post-permanent reconstruction"
            }, 
            {
                "description": "Subject assessment", 
                "measure": "Subject satisfaction scores", 
                "safety_issue": "No", 
                "time_frame": "At 6 and 12 months post-mastectomy and 24 months post-permanent reconstruction"
            }
        ], 
        "overall_contact": {
            "email": "k.breuing@kliniken-essen-mitte.de", 
            "last_name": "Karl Breuing, MD, FACS", 
            "phone": "+49 201 17433509"
        }, 
        "overall_official": {
            "affiliation": "Interdisciplinary Breast Center - Clinic for Senology", 
            "last_name": "Dr. Karl Breuing", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Ethics Commission", 
                "France: Institutional Ethical Committee", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "United Kingdom: National Institute for Health Research", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of planned and unplanned post-mastectomy surgical interventions per subject", 
            "safety_issue": "Yes", 
            "time_frame": "Within 12 months of the initial study surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01910298"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Analysed per breast and per subject.", 
            "measure": "Number of breast-reconstruction related surgical complications", 
            "safety_issue": "Yes", 
            "time_frame": "At 6 and 12 months post-mastectomy and 24 months post-permanent reconstruction"
        }, 
        "source": "LifeCell", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LifeCell", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}